HeadacheTurkiye

Burcu Polat, MD Neurologist, Istanbul, Headache Medicine. 💫Fellowship of the @UEMS_Neurology. 💫Global Migraine Pain Society @aynurozge1 💫@ihs_official

[HeadacheTurkiye @HeadacheTurkey]

Migren hayatınızı nasıl etkiliyor? Migren, başınızın içinde gök gürlüyor ya da şimşek çakıyor gibi hissettirebilir ve siz özellikle de önemli anlarınızda bunu belli etmemenin yollarını ararsınız. Fakat, bu böyle olmak zorunda değil..⁦@globalmigraine⁩ ⁦@ihs_official⁩

[International Headache Society @ihs_official]

Migraine is a debilitating neurological disorder affecting over 1 billion people, about 14–15% of the global population. Women are three times more likely to be affected, highlighting a major gender disparity.

In this Episode 1 'Pain & Prejudice', Anette shares her lifelong journey with severe migraine. The film features insights from leading experts: Prof. Cristina Tassorelli (Italy), Prof. Robert Shapiro (USA), Prof. Christian Lampl (Austria), and Asst. Prof. Jelena Pavlovic (USA).

It also includes perspectives from patient advocates Heather Phillips (American Migraine Foundation) and Elena Ruiz de La Torre (European Migraine and Headache Alliance), highlighting the importance of advocacy and improved access to care.

To see the full video: https://t.co/MsiRoETK8M

#MAM2025 #migraineawareness

[International Headache Society @ihs_official]

June is Migraine Awareness Month

Migraine is a debilitating neurological disorder that affects over 1 billion people worldwide, with 14–15% of the global population experiencing it. Women are two to three times more likely to be affected, often due to hormonal influences.

This June, let’s raise awareness and advocate for better care for those living with #migraine.

#MAM2025 #migraineawareness

[International Headache Society @ihs_official]

🕒 Super Early Bird Registration Ends Soon – Don’t Miss This Scientific Milestone!

The 22nd International Headache Congress (IHC 2025) will bring groundbreaking advancements in headache medicine, featuring:

✅ Latest research on pathophysiology & biomarkers
✅ Innovative treatment strategies & AI in headache medicine
✅ Breakthroughs in migraine prevention & patient care

Be part of the most comprehensive scientific programme in headache research!

🎟 Register before March 10 to secure the Super Early Bird rate!

🔗 https://t.co/O4H2bE3zWt

📅September 10–13, 2025
📍 WTC São Paulo, Brazil

#IHC2025 #HeadacheResearch #MedicalScience #Neurology

[aynurozge @aynurozge1]

https://t.co/6oYjqmHKEF
Let’s talk about Neuro- Behcet disease. @globalmigraine @noromofficial

[International Headache Society @ihs_official]

February 14 is TTH Awareness Day!

Episodic tension-type headache occurs <15 days/month, is typically bilateral, pressing or tightening, mild to moderate, and lasts 30 minutes to 7 days. It does not worsen with routine activity or cause nausea, though photophobia or phonophobia may occur.

#TTHawareness #TTH2025

[International Headache Society @ihs_official]

🎉✨ Celebrating Our Exceptional Peer Reviewers for Cephalalgia

On behalf of the entire Cephalalgia journal team, we extend our deepest gratitude and heartfelt congratulations to our exceptional peer reviewers for their invaluable contributions:

Gregory Dussor (U.S.A.)
David Garcia-Azorin (Spain)
Roberta Messina (Italy)
Raffaele Ornello (Italy)
Aynur Özge (Turkey)
Lanfranco Pellesi (Denmark)

Their dedication, expertise, and insightful feedback have been instrumental in ensuring the high quality and rigor of Cephalalgia.

✨ Exceptional reviewers were selected based on:

Number of reviews completed
Ratio of reviews accepted versus invitations sent
Timeliness in completing reviews
Quality of review reports

📢 Join Our Reviewer Team!
Are you passionate about advancing headache research and ensuring academic rigor? We’re looking to expand and diversify our reviewer base. If you’re interested in becoming a peer reviewer, please email us your areas of expertise and Scopus ID. Your contributions can help shape the future of headache research!

#Cephalalgia #PeerReview #AcademicExcellence #migraine #headache #brain #pain #neurology #neuroscience

[International Headache Society @ihs_official]

IHC 2025: Making History in Latin America!

Join us in São Paulo, 10–13 September 2025, for a groundbreaking event dedicated to the future of global headache care.

#SaveTheDate #IHC2025 #headache

[International Headache Society @ihs_official]

Save the date! Join us for the International Headache Congress 2025 in São Paulo, 10-13 September!

For the first time in Latin America, over 100 experts from 30+ countries will share groundbreaking advances in headache care. Don’t miss this unique scientific and cultural experience!

#headache #migraine #congress

[International Headache Society @ihs_official]

🎉 The IHS Child and Adolescent Committee Webinar recording is now available on the IHS Learning Centre!

Hear from Dr. Mona Nada, Dr. Pinar Topaloğlu, and Dr. Aynur Özge on migraine prevention, device treatments, and behavioral approaches for young patients.

#NeuroTwitter
#migraine #learning

[Paolo Martelletti @P_Martelletti]

Today in Istanbul at Acibadem University. https://t.co/H1USLDbQHS

[globalmigrainepain @globalmigraine]

Trigeminal Nevralji'nin Gizli Yüzü
"Trigeminal Nevralji, görünmeyen ama hayatı zorlaştıran bir hastalık. Sessizce yaşayanların sesine kulak verelim. #GörünmeyenAğrı #TrigeminalNevralji # TürkDişHekimleriBirliği

[globalmigrainepain @globalmigraine]

Trigeminal Nevralji nedir?
"Yüzde aniden hissedilen keskin, elektrik çarpması gibi bir ağrı mı yaşıyorsunuz? Bu Trigeminal Nevralji olabilir. Yüz sinirini etkileyen bu ağrıya dikkat edelim! #TrigeminalNevralji #FarkındalıkGünü #MigraineAndPain"

[aynurozge @aynurozge1]

Trigeminal Nevralji nasıl tedavi edilir? https://t.co/zXQfOIFwVc @YouTube aracılığıyla @ihs_official @globalmigraine @hamitgenc

[aynurozge @aynurozge1]

Trigeminal Nevralji nasıl teşhis edilir? https://t.co/KOlyrJrQn8 @YouTube aracılığıyla @ihs_official @globalmigraine @elifkocasoyorhan

[aynurozge @aynurozge1]

Trigeminal Nevralji nedir? https://t.co/491ieSoWU9 @YouTube aracılığıyla. @ihs_official @globalmigraine @elifilgaz

[International Headache Society @ihs_official]

Today is Trigeminal Neuralgia Awareness Day!

#TrigeminalNeuralgia is characterized by recurrent, brief electric shock-like pains on one side of the face, triggered by innocuous stimuli. Let’s come together to raise awareness and support those enduring this condition. Together, we can make a difference.

[International Headache Society @ihs_official]

Clinical and biological features associate with migraine treatment responses. Research that validates and expands upon existing findings in clinical settings is needed to achieve precision medicine for migraine treatment.

Precision medicine for migraine aims to tailor treatments based on individual patient characteristics, potentially speeding up the process of finding effective, tolerable therapies.
Clinical, genomic, proteomic, physiologic, and brain imaging markers may predict how well patients respond to acute and preventive migraine treatments.
Further research is needed to develop predictive models for treatment responses, helping clinicians choose the best treatment options for each patient.
https://t.co/HHfM2WT4bb
#headache #migraine #neurology